Jae-ouk Kim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Dose-dependent serological profiling of AdCLD-CoV19-1 vaccine in adults.
Journal: mSphere
Published: December 26, 2024
Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 26, 2024
One-year antibody durability induced by EuCorVac-19, a liposome-displayed COVID-19 receptor binding domain subunit vaccine, in healthy Korean subjects.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: July 06, 2023
Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants.
Journal: Vaccine
Published: June 23, 2022
The Chimeric Adenovirus (Ad5/35) Expressing Engineered Spike Protein Confers Immunity against SARS-CoV-2 in Mice and Non-Human Primates.
Journal: Vaccines
Published: April 06, 2022
Amelioration of SARS-CoV-2 infection by ANO6 phospholipid scramblase inhibition.
Journal: Cell reports
Published: July 05, 2021
Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, Euvichol, in an animal model.
Journal: Clinical and experimental vaccine research
Published: July 17, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026